Suppr超能文献

慢性一氧化氮合酶抑制对大鼠脑小动脉的影响。

Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats.

作者信息

Chillon J M, Ghoneim S, Baumbach G L

机构信息

Department of Pathology, University of Iowa College of Medicine and Cardiovascular Center, Iowa City 52242, USA.

出版信息

Hypertension. 1997 Nov;30(5):1097-104. doi: 10.1161/01.hyp.30.5.1097.

Abstract

We examined the effects of nitric oxide (NO) synthase inhibition on the structure and mechanics of cerebral arterioles. We measured pressure, diameter, and cross-sectional area of the vessel wall (histologically) in maximally dilated cerebral arterioles in Sprague-Dawley rats that were untreated or treated for 3 months with the NO synthase inhibitor N-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg per day). Treatment with L-NAME increased cerebral arteriolar mean (87+/-6 versus 42+/-2 mm Hg, P<.05) and pulse (25+/-2 versus 13+/-2 mm Hg, P<.05) pressures, as well as cross-sectional area of the vessel wall (1839+/-70 versus 1019+/-58 microm2, P<.05) and external diameter (101+/-4 versus 87+/-2 microm, P<.05). These findings suggest that hypertension induced by NO synthase inhibition is accompanied by hypertrophy of the vessel wall and enlargement of cerebral arterioles in rats. To determine the role of cerebral arteriolar pulse pressure in hypertrophy of cerebral arterioles during inhibition of NO synthase, we measured the cross-sectional area of the vessel wall in rats treated with L-NAME that underwent unilateral carotid clipping. Unilateral carotid clipping failed to prevent increases in cross-sectional area of the vessel wall (1507+/-173 and 1613+/-148 microm2 in the clip and sham sides, respectively) in rats treated with L-NAME, even though increases in pulse pressure were prevented (16+/-1 and 27+/-1 mm Hg in the clip and sham sides, respectively, P<.05). These findings suggest that inhibition of NO synthase may promote hypertrophy of cerebral arterioles independently of increases in arteriolar pulse pressure.

摘要

我们研究了一氧化氮(NO)合酶抑制对脑小动脉结构和力学的影响。我们测量了未治疗或用NO合酶抑制剂N-硝基-L-精氨酸甲酯(L-NAME;每天10mg/kg)治疗3个月的Sprague-Dawley大鼠最大扩张脑小动脉的压力、直径和血管壁横截面积(组织学测量)。用L-NAME治疗可增加脑小动脉平均压力(87±6对42±2mmHg,P<0.05)和脉压(25±2对13±2mmHg,P<0.05),以及血管壁横截面积(1839±70对1019±58μm²,P<0.05)和外径(101±4对87±2μm,P<0.05)。这些发现表明,NO合酶抑制诱导的高血压伴有大鼠血管壁肥大和脑小动脉扩张。为了确定脑小动脉脉压在NO合酶抑制期间脑小动脉肥大中的作用,我们测量了接受单侧颈动脉夹闭的L-NAME治疗大鼠的血管壁横截面积。尽管单侧颈动脉夹闭可防止脉压升高(夹闭侧和假手术侧分别为16±1和27±1mmHg,P<0.05),但未能阻止L-NAME治疗大鼠血管壁横截面积增加(夹闭侧和假手术侧分别为1507±173和1613±148μm²)。这些发现表明,NO合酶抑制可能独立于小动脉脉压升高而促进脑小动脉肥大。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验